People with aphasia-a brain disorder affecting about a million people in the U.S.-struggle to turn their thoughts into words and comprehend spoken language.
Gilead and Terray to develop small-molecule therapies
The partnership leverages Terray’s AI-driven platform designed to enhance drug discovery through high-throughput chemical experimentation. Credit: Collagery/Shutterstock. Gilead Sciences has entered a strategic partnership with